Ligand Pharmaceuticals (LGND) Goodwill & Intangibles (2016 - 2025)
Ligand Pharmaceuticals' Goodwill & Intangibles history spans 16 years, with the latest figure at $101.5 million for Q3 2025.
- For Q3 2025, Goodwill & Intangibles fell 73.29% year-over-year to $101.5 million; the TTM value through Sep 2025 reached $101.5 million, down 73.29%, while the annual FY2024 figure was $371.9 million, 22.61% up from the prior year.
- Goodwill & Intangibles for Q3 2025 was $101.5 million at Ligand Pharmaceuticals, roughly flat from $101.5 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $709.6 million in Q2 2022 and bottomed at $101.5 million in Q2 2025.
- The 5-year median for Goodwill & Intangibles is $392.5 million (2024), against an average of $419.0 million.
- The largest annual shift saw Goodwill & Intangibles soared 182.68% in 2021 before it crashed 73.86% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $376.7 million in 2021, then grew by 18.96% to $448.1 million in 2022, then plummeted by 32.32% to $303.3 million in 2023, then grew by 22.61% to $371.9 million in 2024, then crashed by 72.7% to $101.5 million in 2025.
- Per Business Quant, the three most recent readings for LGND's Goodwill & Intangibles are $101.5 million (Q3 2025), $101.5 million (Q2 2025), and $371.9 million (Q4 2024).